Aug PBS price reductions
July 29, 2013
Simvastatin and clopidogrel
are among a range of medications
which will see significant price cuts
later this week, as the next round
of the government’s PBS reforms
kicks in from 01 August.
The Health Department has
posted details of the latest round
of changes, with the Weighted
Average Percentage Reduction for
simvastatin being a hefty 44.66%.
Clopidogrel is subject to a 43.75%
cut, while other reductions include
a 39.7% drop in the price of
risperidone.
The PBS website confirms that
these reductions are for drugs
and manners of administration
that were directly affected by the
December 2012 Federal Court
judgement around treatment of
delisted brands in price disclosure.
Brands that were not affected by
this judgement have already had
their prices reduced on 01 April.
A total of 41 molecules are
impacted this time around, with
price cuts also applying to such
items as amoxycillin, cephalexin,
clarithromycin, pravastatin,
fluoxetine, gemcitabine, paroxetine,
sertraline and omeprazole.
There are also price cuts to
dexamethasone and temozolomide.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jul 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jul 13
